£142.5 M

QP.L Mkt cap, 31-Oct-2017

£51.4 M

Quantum Pharma Revenue FY, 2017
Quantum Pharma Gross profit (FY, 2017)18.3 M
Quantum Pharma Gross profit margin (FY, 2017), %35.6%
Quantum Pharma Net income (FY, 2017)-10.9 M
Quantum Pharma EBITDA (FY, 2017)-9.2 M
Quantum Pharma EBIT (FY, 2017)-10 M
Quantum Pharma Cash, 31-Jan-20172.7 M

Quantum Pharma Financials

Quantum Pharma Income Statement

Annual

GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

29.7 m35 m33.4 m35.2 m41 m47.3 m47.5 m51.4 m

Revenue growth, %

15%13%

Cost of goods sold

18.1 m18 m17.8 m19.2 m23.8 m26.5 m29.7 m33 m

Gross profit

11.5 m17 m15.6 m16 m17.2 m20.8 m17.8 m18.3 m

Gross profit Margin, %

39%49%47%45%42%44%37%36%

Operating expense total

1.6 m2.6 m4.3 m6.1 m6.7 m8.4 m11 m15.5 m10.6 m28.4 m

EBITDA

2.4 m5.9 m7.5 m11.2 m9.2 m8 m6.6 m5.8 m7.9 m(9.2 m)

EBITDA margin, %

25%32%28%23%16%12%17%(18%)

EBIT

2.3 m5.7 m7.3 m10.9 m8.9 m7.6 m6.3 m5.3 m7.2 m(10 m)

EBIT margin, %

24%31%27%22%15%11%15%(20%)

Pre tax profit

2.2 m5.6 m7.3 m10.9 m9 m6.8 m8.1 m5.7 m7.9 m(9.4 m)

Income tax expense

(719 k)(1.6 m)(2.1 m)(3.1 m)(1.9 m)(2.2 m)(799 k)(888 k)(1.3 m)(1.5 m)

Net Income

1.5 m4 m5.1 m7.8 m7 m4.6 m7.3 m4.8 m6.6 m(10.9 m)

Quantum Pharma Balance Sheet

Annual

GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

983 k2.5 m1.9 m3.6 m2.5 m4.4 m2.7 m2.2 m1.9 m2.7 m

Accounts Receivable

1.9 m5.2 m6.2 m6.5 m6 m7.4 m6.2 m7.2 m6.7 m6.4 m

Inventories

213 k323 k466 k512 k497 k743 k1 m1.7 m1.9 m1.5 m

Current Assets

3.1 m8.3 m9 m11.6 m13 m19.9 m22.9 m27.9 m33.7 m34.4 m

PP&E

1.1 m1 m2.6 m2.6 m4.9 m2.3 m2.3 m3.4 m3.9 m2.9 m

Goodwill

93 k

Total Assets

4.2 m10.3 m11.9 m16.2 m20.4 m40.1 m49.9 m70 m76.3 m67 m

Accounts Payable

889 k2.1 m2.9 m3.7 m4.8 m3.9 m4.2 m3.9 m4.8 m5.6 m

Current Liabilities

3 m6.7 m7.6 m9.6 m10.3 m28.7 m33.1 m50.6 m50.2 m51.3 m

Non-Current Liabilities

102 k106 k127 k87 k3 k175 k180 k161 k

Total Liabilities

3.1 m6.9 m7.8 m9.7 m10.3 m28.7 m33.1 m50.7 m50.4 m51.5 m

Additional Paid-in Capital

1 k1 k1 k1 k1 k1 k1 k1 k1 k1 k

Retained Earnings

531 k2.4 m645 k2.3 m2.5 m93 k4.3 m1.8 m6.6 m(10.9 m)

Total Equity

1.1 m3.5 m4.1 m6.5 m10.1 m11.3 m16.8 m19.3 m25.9 m15.5 m

Financial Leverage

3.8 x3 x2.9 x2.5 x2 x3.5 x3 x3.6 x2.9 x4.3 x

Quantum Pharma Cash Flow

Annual

GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

1.5 m4 m5.1 m7.8 m7 m4.6 m7.3 m4.8 m6.6 m(10.9 m)

Cash From Operating Activities

2.4 m5.2 m

Dividends Paid

974 k1.6 m4.5 m5.5 m4.5 m4.5 m3 m3 m

Net Change in Cash

127 k1.5 m

Income Taxes Paid

(799 k)(888 k)(1.3 m)

Quantum Pharma Ratios

GBPY, 2017

Revenue/Employee

117.5 k

Financial Leverage

4.3 x
Report incorrect company information